Differentiation-inducing agents in the treatment of myelodysplastic syndromes.
Kizaki
M
M
Division of Hematology/Oncology, UCLA School of Medicine.
Koeffler
H P
HP
D000081:Acetamides / Q000627:therapeutic use*; D001374:Azacitidine / Q000627:therapeutic use*; D002117:Calcitriol / Q000031:analogs & derivatives / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D012176:Retinoids / Q000627:therapeutic use*
D000081:Acetamides; D012176:Retinoids; D007372:Interferons; D002117:Calcitriol; C014026:hexamethylene bisacetamide; D001374:Azacitidine